Dark

Check out our API

ARCH
Arch Resources, Inc.
stock NYSE

Inactive

Jan 13, 2025

134.83USD+0.702%(+0.94)3,717,104

Pre-market

0.00USD-100.000%(-133.89)0

After-hours

0.00USD0.000%(0.00)0

OverviewOptionsHistoricalExchangesShortsNews

Jan 4, 2022

07:25AM EST Research Ethics Board approves amendment to Canadian Treatments GlobeNewswire Inc

Jan 3, 2022

07:00AM EST Molly P. Zhang Elected to Arch's Board of Directors PR Newswire

Dec 14, 2021

04:56AM EST HSBC Said Clients Must Have Plan to Exit Coal by the End of 2023 Benzinga

Dec 1, 2021

07:35AM EST Arch Biopartners Lead Drug LSALT Peptide to GlobeNewswire Inc

Nov 24, 2021

03:06PM EST Coal Prices Reach Highest Level In 10+ Years Benzinga

Oct 26, 2021

07:28AM EDT Recap: Arch Resources Q3 Earnings Benzinga

06:42AM EDT Arch Coal Q3 EPS $4.92 Misses $5.77 Estimate, Sales $594.41M Beat $509.87M Estimate Benzinga

06:39AM EDT Arch Coal Inc. (ARCH) Declares Quarterly Dividend of $ 0.25, Record Date 11/30/2021 RTTNews

06:32AM EDT Arch Resources Q3 Net Income $89.1 Mln Or $4.92/shr Vs Loss Of $191.5 Mln Or $12.64/Shr Last Year RTTNews

06:30AM EDT Arch Resources Reports Third Quarter 2021 Results PR Newswire

04:39AM EDT Earnings Scheduled For October 26, 2021 Benzinga

Oct 12, 2021

05:43PM EDT Arch Resources to Announce Third Quarter 2021 Results on October 26 PR Newswire

Oct 8, 2021

07:14AM EDT China State Media Reports China's Cabinet: Will Use Market-oriented Measures to Ensure Coal and Power Supplies Benzinga

Oct 4, 2021

08:49AM EDT B. Riley Securities Maintains Buy on Arch Resources, Raises Price Target to $120 Benzinga

Sep 29, 2021

10:12AM EDT Benzinga's Top Ratings Upgrades, Downgrades For September 29, 2021 Benzinga

07:15AM EDT Citigroup Upgrades Arch Resources to Buy, Raises Price Target to $110 Benzinga

05:43AM EDT China State Planner Says Will Ensure Sufficient Coal Supply for Heating and Power Generation in Northeast China; Will Guide Power Generation and Heating Firms to Increase Coal Imports Benzinga

Sep 27, 2021

10:15AM EDT Mid-Morning Market Update: Markets Mixed; US Durable Goods Orders Increase Sharply In August Benzinga

Sep 9, 2021

06:57AM EDT Arch Commences Production At World-Class Leer South Longwall Mine RTTNews

Sep 2, 2021

07:56AM EDT B. Riley Securities Maintains Buy on Arch Resources, Raises Price Target to $87 Benzinga

Aug 5, 2021

06:30AM EDT Arch Biopartners Provides Update on Phase II Trial for LSALT Peptide GlobeNewswire Inc

Jul 27, 2021

11:13AM EDT Recap: Arch Resources Q2 Earnings Benzinga

06:39AM EDT Arch Coal Q2 EPS $1.66 Beats $0.81 Estimate, Sales $450.39M Beat $359.37M Estimate Benzinga

06:32AM EDT Arch Resources Q2 Net Income $27.9 Mln Or $1.66/Shr Vs Loss Of $49.3 Mln Or $3.26/Shr Last Year RTTNews

06:30AM EDT Arch Resources Reports Second Quarter 2021 Results PR Newswire

04:03AM EDT Earnings Scheduled For July 27, 2021 Benzinga

Jul 14, 2021

07:00AM EDT Arch Scientists Awarded CIHR Grant to Study LSALT for the GlobeNewswire Inc

Jul 12, 2021

07:00AM EDT Arch Resources to Announce Second Quarter 2021 Results on July 27 PR Newswire

Jun 10, 2021

07:20AM EDT Arch Biopartners Files New Patent Application for Novel Antibody GlobeNewswire Inc

May 13, 2021

07:45AM EDT Arch Resources Becomes First U.S. Metallurgical Coal Supplier to Join PR Newswire

May 4, 2021

07:00AM EDT Arch Biopartners Completes Enrollment in Phase II Trial of GlobeNewswire Inc

Apr 22, 2021

12:21PM EDT Earnings Scheduled For April 22, 2021 Benzinga

07:05AM EDT Arch Resources: Q1 Earnings Insights Benzinga

06:44AM EDT Arch Coal Q1 EPS $(0.40) Beats $(0.41) Estimate, Sales $357.54M Beat $320.27M Estimate Benzinga

06:32AM EDT Arch Resources Q1 Net Loss $6.0 Mln Or $0.40/Shr Vs Loss Of $25.3 Mln Or $1.67/Shr Last Year RTTNews

06:31AM EDT Arch Resources Reports First Quarter 2021 Results PR Newswire

04:01AM EDT Earnings Scheduled For April 22, 2021 Benzinga

Apr 21, 2021

10:49AM EDT Earnings Outlook for Arch Coal Benzinga

Apr 15, 2021

07:00AM EDT Arch Biopartners Enters into Worldwide License Agreement with GlobeNewswire Inc

Apr 8, 2021

08:00AM EDT Arch Resources to Announce First Quarter 2021 Results on April 22 PR Newswire

Mar 30, 2021

07:57AM EDT Turkish Ministry of Health Approves Increase in Patient GlobeNewswire Inc

Mar 24, 2021

08:26AM EDT Arch Biopartners Inc. (Arch or the Company) (TSX Venture: ARCH and OTCQB: ACHFF), announced today it has entered into an exclusive agreement with the University of Cincinnati (UC) to license new patent claims for an AB569 topical wound application designed to prevent, treat and heal burn/blast wound infections. GlobeNewswire Inc

Mar 16, 2021

08:33AM EDT Arch Biopartners Receives Health Canada Authorization to Amend GlobeNewswire Inc

Mar 4, 2021

09:03AM EST Arch Resources Issues $45.0 Mln In Tax-Exempt Bonds RTTNews

09:00AM EST Arch Resources Issues $45.0 Million in Tax-Exempt Bonds PR Newswire

08:33AM EST ARCH Scientist Publishes Paper Showing Pre-Clinical Efficacy of GlobeNewswire Inc

Feb 26, 2021

08:43AM EST Peter Lougheed Centre Joins the Phase II Trial of LSALT Peptide GlobeNewswire Inc

Feb 13, 2021

12:54PM EST The Past Week's Notable Insider Buys: Biotech IPOs, Curiositystream, Greenbrier And More Benzinga

Feb 9, 2021

06:42AM EST Arch Coal Q4 Sales $360.58M Beat $330.93M Estimate Benzinga

06:32AM EST Arch Resources Q4 Net Loss $78.5 Mln Or $5.17/Shr Vs Loss Of $8.6 Mln Or $0.57/Shr Last Year RTTNews

06:30AM EST Arch Resources Reports Fourth Quarter 2020 Results PR Newswire

04:05AM EST Earnings Scheduled For February 9, 2021 Benzinga

Feb 2, 2021

07:56AM EST Arch Biopartners Receives Ethics Committee Approval in Turkey to GlobeNewswire Inc

Jan 26, 2021

05:00PM EST Arch Resources to Announce Fourth Quarter and Full Year 2020 Results on PR Newswire

Jan 5, 2021

07:50AM EST University of Calgary Joins the Phase II Trial of LSALT Peptide GlobeNewswire Inc

Dec 15, 2020

01:05PM EST IIROC Trading Resumption - ARCH PR Newswire

12:52PM EST -- Government of Canada contribution up to $6.7 Million -- Funding from the department of Innovation, Science and Economic Development through the Strategic Innovation Fund and part of the Government of Canadas Plan to Mobilize Science to fight COVID-19 -- Metablok is a novel Canadian drug candidate designed to prevent organ inflammation, which occurs in severe cases of COVID-19 GlobeNewswire Inc

11:36AM EST IIROC Trading Halt - ARCH PR Newswire

Dec 10, 2020

07:27AM EST VA San Diego Healthcare System Joins the Phase II Trial of LSALT GlobeNewswire Inc

Nov 3, 2020

07:38AM EST UPDATE: Arch Resources Says MSHA Has Allowed Mining To Resume At Beckley Pocahontas Mine Benzinga

07:38AM EST Arch Resources On October 29, Unit ICG Beckley Received An Imminent Danger Order At Beckley Pocahontas Mine Located In Raleigh County, Danger Order States That An Examiner Found An Accumulation Of Elevated Methane Levels In Beckley Pocahontas Mine Benzinga

Oct 29, 2020

11:23PM EDT Arch Resources Prices $135.0 Mln Convertible Senior Notes Offering RTTNews

10:58PM EDT Arch Resources, Inc. Prices $135.0 Million Convertible Senior Notes Offering PR Newswire

Oct 28, 2020

05:01PM EDT Arch Resources Intends To Offer $125 Mln Of Convertible Senior Notes Due 2025 RTTNews

04:51PM EDT Arch Resources, Inc. Announces Proposed Convertible Senior Notes Offering PR Newswire

Oct 23, 2020

07:14AM EDT Benchmark Maintains Buy on Arch Resources, Lowers Price Target to $54 Benzinga

Oct 22, 2020

07:35AM EDT Arch Resources: Q3 Earnings Insights Benzinga

06:44AM EDT Arch Coal Q3 EPS $(12.64) Down From $6.34 YoY Benzinga

06:31AM EDT Arch Resources Q3 Net Loss $191.5 Mln Or $12.64/Shr Vs Net Income Of $106.8 Mln Or $6.34/Shr Last Year RTTNews

06:31AM EDT Arch Resources Reports Third Quarter 2020 Results PR Newswire

04:38AM EDT Earnings Scheduled For October 22, 2020 Benzinga

Oct 16, 2020

07:00AM EDT Arch Biopartners Inc. (Arch or the Company) (TSX Venture: ARCH and OTCQB: ACHFF), announced today it has dosed the first patient in the Phase II trial of its lead drug LSALT peptide, targeting prevention of acute lung injury, acute kidney injury and other complications caused by inflammation in hospitalized patients with moderate to severe cases of COVID-19. GlobeNewswire Inc

Oct 15, 2020

07:33AM EDT Arch Resources: Leer Mine Wins Sentinels Of Safety Award For Large Underground Mines RTTNews

07:30AM EDT Arch Subsidiaries Claim Three of Nation's Most Prestigious Awards for Safety PR Newswire

Oct 14, 2020

07:31AM EDT Arch Resources Appoints Rosemary Klein As General Counsel And Corporate Secretary RTTNews

07:31AM EDT Arch Resources Names Rosemary L. Klein General Counsel and Corporate Secretary PR Newswire

Oct 8, 2020

05:00PM EDT Arch Resources to Announce Third Quarter 2020 Results on October 22 PR Newswire

Oct 7, 2020

07:58AM EDT Arch Biopartners Inc. (Arch or the Company) (TSX Venture: ARCH and OTCQB: ACHFF), announced today that it received approval in Turkey from the Ministry of Health to proceed with the Phase II trial of its lead drug LSALT peptide (Metablok), targeting acute lung injury and acute kidney injury caused by inflammation in patients with moderate to severe cases of COVID-19. GlobeNewswire Inc

Oct 5, 2020

04:38PM EDT Arch Resources 13G Filing From Morgan Stanley Shows 6.1% Stake In Co. Benzinga

Sep 29, 2020

11:51AM EDT Arch Resources Announces It Will Terminate Proposed Thermal Asset Joint Venture With Peabody Following U.S. District Court Ruling To Block The Transaction Benzinga

11:48AM EDT Arch to drive forward with strategic pivot towards steel and metallurgical PR Newswire

Sep 1, 2020

08:00AM EDT Arch Biopartners Announces Application to the Turkish Ministry of GlobeNewswire Inc

Aug 21, 2020

08:00AM EDT Arch Biopartners Inc. (Arch or the Company) (TSX Venture: ARCH and OTCQB: ACHFF) announced it has obtained eligibility with The Depository Trust Company (DTC) in the United States, increasing access for U.S. investors for its common shares listed on the OTCQB. GlobeNewswire Inc

Aug 7, 2020

11:35AM EDT Arch Biopartners to Hold LSALT Peptide Webinar and Q&A Session GlobeNewswire Inc

Aug 4, 2020

08:01AM EDT Arch Biopartners Inc. (Arch or the Company) (TSX Venture: ARCH and OTCQB: ACHFF), announced today that it received independent Institutional Review Board (IRB) approval for the Phase II trial of its lead drug LSALT peptide (Metablok) targeting acute lung injury and acute kidney injury caused by inflammation in patients with severe cases of COVID-19. GlobeNewswire Inc

Jul 28, 2020

10:21AM EDT Recap: Arch Resources Q2 Earnings Benzinga

08:14AM EDT Broward Health Medical Center Becomes First Clinical Site in U.S. GlobeNewswire Inc

06:36AM EDT Arch Coal Q2 EPS $(3.26) Misses $(2.50) Estimate, Sales $319.52M Beat $300.40M Estimate Benzinga

06:32AM EDT Arch Resources Q2 Net Loss $49.3 Mln Or $3.26/Shr Vs Income Of $62.8 Mln Or $3.53/Shr Last Year RTTNews

06:30AM EDT Arch Resources Reports Second Quarter 2020 Results PR Newswire

04:05AM EDT Earnings Scheduled For July 28, 2020 Benzinga

Jul 16, 2020

04:30PM EDT Arch Resources to Announce Second Quarter 2020 Results on July 28 PR Newswire

Jul 14, 2020

07:00AM EDT Arch Biopartners Engages Global CRO to Conduct LSALT peptide GlobeNewswire Inc

Share